The prestigious New England Journal of Medicine (NEJM) has published interim results from the Phase III trial of Japanese drug major Takeda Pharma’s (TYO: 4502) Adzynma (apadamtase ...

Sentynl Therapeutics, the USA-based wholly-owned subsidiary of Indian generics major Zydus Lifesciences (NYSE: ZYDUSLIFE), has announced the closing of the sale of Eiger BioPharmaceuticals’ (OTC: ...

Danish diabetes giant Novo Nordisk (NOV: N) today reported financial results for the first quarter of 2024, noting that sales ...

The UK pharma sector is dynamic, supported by a government-led drive to make the UK a ‘Science Superpower’. 1 This steer from the government, alongside a strong patient advocacy landscape and ...

The UK’s medicines regulator has set out its strategic approach to artificial intelligence (AI).

Sentynl, the USA-based wholly-owned subsidiary of Indian generics major Zydus Lifesciences, has announced the closing of the sale of Eiger BioPharmaceuticals’ Zokinvy (lonafarnib) program to Sentynl.

Genmab (CPH: GMAB) continues to thrive. The Danish biotech company reported its financial results for the first quarter of 2024 on Thursday, sending shares up by 5% in the following day’s trading.

Philadelphia, USA-based Reunion Neuroscience, a company developing psychedelics for the treatment of mental health conditions, has announced the closing of a $103 million Series A financing.

California-based biopharma BridgeBio Pharma (Nasdaq: BBIO) has announced the completion of a $200 million private financing of its former subsidiary, TheRas. Doing business as BridgeBio Oncology ...

US cancer drug developer Context Therapeutics (Nasdaq: CNTX) saw its share close up 27.3% at $1.75 yesterday, after it revealed it has entered into a securities purchase agreement with certain new and ...

Osaka, Japan-based drugmaker Ono Pharmaceutical (TYO: 4528) has entered into a drug discovery collaboration agreement with ...

Swiss pharma giant Novartis (NOVN VX) has entered into an agreement to acquire USA-based biotech start-up Mariana Oncology, which is focused on developing novel radioligand therapies (RLTs) to ...